celecoxib has been researched along with Hives in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms." | 5.91 | Angioedema without urticaria after recent initiation of celecoxib. ( Abdujelil, I; Anderson, J; Jasti, VV, 2023) |
| " Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam)." | 5.11 | Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. ( Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G, 2004) |
| "Patients with NSAID-induced urticaria or angioedema were challenged in a double-masked, placebo-controlled design protocol with etoricoxib (120 mg) and celecoxib (200 mg)." | 5.11 | Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. ( Caballero-Fonseca, F; Capriles-Hulett, A; Sánchez-Borges, M, 2005) |
| "Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms." | 1.91 | Angioedema without urticaria after recent initiation of celecoxib. ( Abdujelil, I; Anderson, J; Jasti, VV, 2023) |
| "Cyclical anaphylactoid reactions associated with menstruation are exceedingly rare." | 1.31 | Anaphylactoid reactions associated with menstruation affecting two sisters. ( Humphrey, MD; Roomes, D; Simpson, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jasti, VV | 1 |
| Anderson, J | 1 |
| Abdujelil, I | 1 |
| Caimmi, SM | 1 |
| Manca, E | 1 |
| Caimmi, D | 1 |
| Marseglia, GL | 1 |
| Demoly, P | 1 |
| Kasemsarn, P | 1 |
| Kulthanan, K | 1 |
| Tuchinda, P | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| García-Rodríguez, RM | 1 |
| Hinojosa, M | 1 |
| Camacho-Garrido, E | 1 |
| Berges Gimeno, P | 1 |
| Martín García, C | 1 |
| Zembowicz, A | 1 |
| Mastalerz, L | 2 |
| Setkowicz, M | 1 |
| Radziszewski, W | 1 |
| Szczeklik, A | 2 |
| Rodríguez, M | 1 |
| Enrique, E | 1 |
| Castello, JV | 1 |
| de Mateo, JA | 1 |
| Roca, B | 1 |
| Malek, T | 1 |
| Senna, G | 1 |
| Bilò, MB | 1 |
| Antonicelli, L | 1 |
| Schiappoli, M | 1 |
| Crivellaro, MA | 1 |
| Bonadonna, P | 1 |
| Dama, AR | 1 |
| Liccardi, G | 1 |
| D'Amato, G | 1 |
| Canonica, GW | 1 |
| Lobefalo, G | 1 |
| Noschese, P | 1 |
| Piccolo, A | 1 |
| Salzillo, A | 1 |
| Passalacqua, G | 1 |
| Celik, G | 1 |
| Paşaoğlu, G | 1 |
| Bavbek, S | 1 |
| Abadoğlu, O | 1 |
| Dursun, B | 1 |
| Mungan, D | 1 |
| Misirligil, Z | 1 |
| Sánchez-Borges, M | 1 |
| Caballero-Fonseca, F | 1 |
| Capriles-Hulett, A | 1 |
| Sanak, M | 1 |
| Gawlewicz, A | 1 |
| Gielicz, A | 1 |
| Faber, J | 1 |
| Simpson, G | 1 |
| Roomes, D | 1 |
| Humphrey, MD | 1 |
| Kelkar, PS | 1 |
| Butterfield, JH | 1 |
| Teaford, HG | 1 |
5 trials available for celecoxib and Hives
| Article | Year |
|---|---|
Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Celecoxib; Comput | 2003 |
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celec | 2004 |
Safety of celecoxib in patients with adverse reactions to nimesulide.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Hypers | 2005 |
Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchial Spasm; Celecoxib; Cy | 2005 |
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygen | 2005 |
8 other studies available for celecoxib and Hives
| Article | Year |
|---|---|
Angioedema without urticaria after recent initiation of celecoxib.
Topics: Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Skin; Urticaria | 2023 |
NSAID hypersensitivity in twins.
Topics: Adolescent; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Celecoxib; Child; Ch | 2014 |
Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cel | 2011 |
Celecoxib, safe in NSAID intolerance.
Topics: Administration, Oral; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; C | 2002 |
Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; | 2003 |
Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Drug Hypersensitivity; E | 2006 |
Anaphylactoid reactions associated with menstruation affecting two sisters.
Topics: Adult; Anaphylaxis; Celecoxib; Cyclooxygenase Inhibitors; Female; Follow-Up Studies; Humans; Menstru | 2001 |
Urticaria and angioedema from cyclooxygenase-2 inhibitors.
Topics: Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibito | 2001 |